tiprankstipranks
Trending News
More News >
Q BioMed Inc (QBIO)
OTHER OTC:QBIO
US Market

Q BioMed (QBIO) Ratios

Compare
102 Followers

Q BioMed Ratios

QBIO's free cash flow for Q1 2023 was $0.00. For the 2023 fiscal year, QBIO's free cash flow was decreased by $ and operating cash flow was $-178.00. See a summary of the company’s cash flow.
Ratios
TTM
Nov 22Nov 21Nov 20Nov 19
Liquidity Ratios
Current Ratio
<0.01 <0.01 0.08 0.13 0.04
Quick Ratio
<0.01 <0.01 0.08 0.13 0.04
Cash Ratio
<0.01 <0.01 0.06 0.10 0.03
Solvency Ratio
-0.25 -0.25 -1.49 -7.91 -1.80
Operating Cash Flow Ratio
0.24 0.24 -0.78 -3.67 -0.78
Short-Term Operating Cash Flow Coverage
0.47 0.47 -1.41 -67.62 -1.27
Net Current Asset Value
$ -8.06M$ -8.06M$ -5.04M$ -1.48M$ -5.50M
Leverage Ratios
Debt-to-Assets Ratio
1.17 1.17 3.77 0.15 5.76
Debt-to-Equity Ratio
-0.89 -0.89 -0.65 -0.09 -0.73
Debt-to-Capital Ratio
-8.10 -8.10 -1.87 -0.09 -2.72
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 -0.10
Financial Leverage Ratio
-0.76 -0.76 -0.17 -0.58 -0.13
Debt Service Coverage Ratio
-0.11 -0.11 -2.16 -33.85 -1.69
Interest Coverage Ratio
-2.49 -2.49 -14.58 -44.38 -5.49
Debt to Market Cap
283.27 5.74 0.25 <0.01 0.15
Interest Debt Per Share
0.12 0.12 0.13 0.02 0.34
Net Debt to EBITDA
-6.57 -6.57 -0.35 <0.01 -0.44
Profitability Margins
Gross Profit Margin
-3.16%-3.16%-26.20%-986.70%0.00%
EBIT Margin
-234.79%-234.79%-3953.86%-43986.59%0.00%
EBITDA Margin
-217.21%-217.21%-3928.30%-43819.92%0.00%
Operating Profit Margin
-1211.74%-1211.74%-3777.44%-43818.05%0.00%
Pretax Profit Margin
-721.67%-721.67%-4213.02%-44973.97%0.00%
Net Profit Margin
-721.67%-721.67%-4213.02%-44973.97%0.00%
Continuous Operations Profit Margin
-721.67%-721.67%-4213.02%-44973.97%0.00%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
59.56%59.56%111.53%102.64%128.18%
Return on Assets (ROA)
-58.37%-58.37%-1018.01%-2164.00%-1605.46%
Return on Equity (ROE)
44.12%44.44%175.88%1254.53%203.75%
Return on Capital Employed (ROCE)
74.62%74.62%157.69%1222.28%174.42%
Return on Invested Capital (ROIC)
679.02%679.02%452.64%1336.87%592.00%
Return on Tangible Assets
-63.82%-63.82%-1793.45%-6037.21%-5401.91%
Earnings Yield
-45849.84%-286.56%-68.05%-55.35%-42.72%
Efficiency Ratios
Receivables Turnover
24.65 24.65 2.44 0.00 0.00
Payables Turnover
0.14 0.14 0.18 0.45 0.08
Inventory Turnover
0.00 0.00 11.09 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00
Asset Turnover
0.08 0.08 0.24 0.05 0.00
Working Capital Turnover Ratio
-0.04 -0.04 -0.06 >-0.01 0.00
Cash Conversion Cycle
-2.64K -2.64K -1.81K -808.07 -4.76K
Days of Sales Outstanding
14.81 14.81 149.47 0.00 0.00
Days of Inventory Outstanding
0.00 0.00 32.90 0.00 0.00
Days of Payables Outstanding
2.65K 2.65K 1.99K 808.07 4.76K
Operating Cycle
14.81 14.81 182.37 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
0.04 0.04 -0.16 -0.28 -0.27
Free Cash Flow Per Share
0.04 0.04 -0.16 -0.28 -0.27
CapEx Per Share
<0.01 <0.01 <0.01 0.00 0.00
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
485.35K 485.35K -8.59 -16.62 0.00
Capital Expenditure Coverage Ratio
485.35K 485.35K -1.08M 0.00 0.00
Operating Cash Flow Coverage Ratio
0.47 0.47 -1.41 -67.62 -1.11
Operating Cash Flow to Sales Ratio
6.83 6.83 -21.99 -207.78 0.00
Free Cash Flow Yield
13380.66%271.10%-35.53%-25.57%-17.06%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
>-0.01 -0.35 -1.47 -1.81 -2.34
Price-to-Sales (P/S) Ratio
0.05 2.52 61.91 812.55 0.00
Price-to-Book (P/B) Ratio
>-0.01 -0.16 -2.58 -22.67 -4.77
Price-to-Free Cash Flow (P/FCF) Ratio
<0.01 0.37 -2.81 -3.91 -5.86
Price-to-Operating Cash Flow Ratio
<0.01 0.37 -2.81 -3.91 -5.86
Price-to-Earnings Growth (PEG) Ratio
>-0.01 <0.01 0.03 0.11 -0.14
Price-to-Fair Value
>-0.01 -0.16 -2.58 -22.67 -4.77
Enterprise Value Multiple
-6.60 -7.73 -1.93 -1.85 -3.46
Enterprise Value
4.07M 4.78M 14.82M 24.29M 27.58M
EV to EBITDA
-6.60 -7.73 -1.93 -1.85 -3.46
EV to Sales
14.33 16.80 75.76 809.72 0.00
EV to Free Cash Flow
2.10 2.46 -3.44 -3.90 -6.72
EV to Operating Cash Flow
2.10 2.46 -3.44 -3.90 -6.72
Tangible Book Value Per Share
-0.11 -0.11 -0.19 -0.07 -0.37
Shareholders’ Equity Per Share
-0.10 -0.10 -0.17 -0.05 -0.34
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.00 0.00 0.00
Revenue Per Share
<0.01 <0.01 <0.01 <0.01 0.00
Net Income Per Share
-0.05 -0.05 -0.31 -0.61 -0.68
Tax Burden
1.00 1.00 1.00 1.00 1.00
Interest Burden
3.07 3.07 1.07 1.02 1.28
Research & Development to Revenue
0.44 0.44 5.49 62.67 0.00
SG&A to Revenue
11.54 11.54 32.02 365.64 0.00
Stock-Based Compensation to Revenue
3.18 3.18 11.96 219.14 0.00
Income Quality
-0.95 -0.95 0.52 0.46 0.40
Currency in USD